Incidental Pulmonary Embolism in Cancer Patients

Patients with incidental PE, including those with subsegmental involvement, had increased recurrence rates, despite treatment.

Pulmonary embolism (PE) is often discovered incidentally in oncology patients during their cancer staging and surveillance. Treatment recommendations are typically based on retrospective data, and it is unclear whether outcomes in patients with subsegmental PE differ from those with more proximal PEs.

Here, investigators conducted an international prospective cohort study to analyze rates of recurrent venous thromboembolism (VTE), major bleeding, and all-cause mortality in 695 patients with solid tumor or hematological malignancy and incidental PE. Subgroup analyses were conducted by site of PE (subsegmental vs. more proximal) and intensity of anticoagulation (prophylactic/intermediate vs. therapeutic dosing).

Eligible patients were those wit…

Reviewing Author

Brady L. Stein, MD, MHS

Disclosures

Leadership Positions in Professional SocietiesAmerican Society of Hematology (Senior Editor, ASH Self-Assessment Program; guideline development)

Brady L. Stein, MD, MHS

Disclosures

Leadership Positions in Professional SocietiesAmerican Society of Hematology (Senior Editor, ASH Self-Assessment Program; guideline development)

Incidental Pulmonary Embolism in Cancer Patients

Topics

Reviewing Author